Literature DB >> 16309830

Cystatin C expression is increased in the hippocampus following photothrombotic stroke in rat.

Terhi J Pirttilä1, Asla Pitkänen.   

Abstract

Stroke is a major cause of epilepsy, but the molecular mechanisms underlying post-stroke epileptogenesis are unknown. The expression of cystatin C, a cysteine protease inhibitor, is increased in the hippocampus during status epilepticus (SE)-induced epileptogenesis, and regulates both cell death and birth. To test the hypothesis that increased cystatin C expression represents a common molecular alteration induced by epileptogenic brain insults, we investigated the time course, cellular localization, and association of cystatin C expression with neuronal damage during post-stroke epileptogenesis. Stroke was induced with photothrombosis, which leads to epilepsy in approximately 20-30% of rats. Cystatin C expression was increased in the CA1 area of the hippocampus 4 days after photothrombosis, when the diameter of the lesion was the largest. Double-labeling and confocal analysis indicated that cystatin C was expressed in astrocytes and microglia. Unlike after SE, cystatin C expression did not change in the dentate gyrus. Also, increased cystatin C expression was not associated with neurodegeneration, which was demonstrated as an absence of Fluoro Jade B-positive cells in adjacent sections. The present study provides evidence that cystatin C may be involved in cellular alterations that occur after an epileptogenic insult, not only after SE but also after photothrombotic stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309830     DOI: 10.1016/j.neulet.2005.10.091

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack.

Authors:  Xiaoyu Dong; Jianfei Nao
Journal:  Neurotox Res       Date:  2019-07-02       Impact factor: 3.911

2.  Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke.

Authors:  Bo Yang; Jiangtao Zhu; Zhigang Miao; Beiqun Zhou; Wei Ge; Heqing Zhao; Xingshun Xu
Journal:  Neurotox Res       Date:  2015-02-20       Impact factor: 3.911

Review 3.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

Review 4.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

5.  Cystatin C in Alzheimer's disease.

Authors:  Gurjinder Kaur; Efrat Levy
Journal:  Front Mol Neurosci       Date:  2012-07-06       Impact factor: 5.639

6.  Cystatin C has a dual role in post-traumatic brain injury recovery.

Authors:  Marina Martinez-Vargas; Maribel Soto-Nuñez; Erika Tabla-Ramon; Barbara Solis; Ruben Gonzalez-Rivera; Adan Perez-Arredondo; Francisco Estrada-Rojo; Andres Castell; Juan Molina-Guarneros; Luz Navarro
Journal:  Int J Mol Sci       Date:  2014-04-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.